Loading...
NPI 1831413772 · Oxford, MS · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Oxford Urocare PLLC is a ambulatory surgical clinic/center provider located in Oxford, Mississippi. This profile covers 28 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Oxford Urocare PLLC |
| Address | 1201 Medical Park Dr Ste 101 |
| City | Oxford |
| State | MS |
| ZIP | 38655 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | March 22, 2010 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3M |
| Medicaid | $67.6K |
Business profile: The code mix is consistent with an ambulatory surgical clinic focused on urologic procedures and implantable neuromodulation therapy. High-revenue Medicare codes include 64590 and 64561 (surgical implant/replacement of neurostimulator pulse generators and sacral electrode implantation) and multiple cystourethroscopy and transprostatic implant codes such as C9740 and 52204, indicating the site performs both advanced implant procedures and high-volume cystoscopic diagnostic and therapeutic work. This pattern is typical of an ASC that manages outpatient urologic surgeries, device implants, and endoscopic stone and biopsy interventions.
Medicare revenue concentration: The provider’s Medicare revenue is heavily concentrated in a small set of procedures — the top 3 Medicare codes by revenue account for 71.0% of total Medicare revenue. Those top drivers are led by neurostimulation implantation and sacral electrode procedures (64590 and 64561) plus cystourethroscopy/transprostatic implant work (C9740), showing reliance on a few high-revenue service lines for the majority of Medicare income.
Medicaid revenue concentration and payer mix: Medicaid activity is effectively concentrated in a single service line, with 52000 accounting for $67.7K and 100.0% of this provider’s total Medicaid revenue. Overall payer mix is Medicare-dominant by scale — Total Medicare revenue is $3M compared with Total Medicaid revenue of $67.6K, indicating Medicaid represents a small fraction of the business and the provider operates as an overwhelmingly Medicare-funded ambulatory surgery practice.
Competitive standing on neuromodulation codes: The provider ranks at the top of the national distribution for implantable neuromodulation work, with 64590 at #9 of 561 providers and 64561 at #8 of 564 providers (both 99th percentile and described as notably above typical national volume). These ranks position the clinic as a major national-volume provider for sacral/gastric/peripheral neurostimulator implant procedures rather than a modest local operator.
Procedural volume outliers in cystoscopy: The clinic is an extreme national outlier on several cystoscopic codes. Medicare activity shows 52000 with 788 claims (rank #35 of 8548, 100th percentile; labeled an extreme outlier) and 52204 at rank #1 of 370 providers (100th percentile; extreme outlier). These standings suggest the center performs unusually high volumes of basic cystourethroscopy and cystoscopic biopsy relative to peers.
State-level dominance for Medicaid cystoscopy: For Medicaid, 52000 appears as the dominant in-state billed service, with 787 claims, $86 avg paid/claim, $67.7K revenue and ranked #1 of 10 providers in-state (100th percentile; notably above typical state volume). This indicates the facility is a primary Medicaid cystoscopy provider in its state market despite Medicaid representing a small share of total revenue.
Service-line nuance and lower-revenue items: The practice also bills a wide range of endoscopic and lithotripsy codes (for example, 52356, 50590, 52332) and limited onabotulinumtoxinA units (J0585) where volume and dollars are modest; J0585 generates $17.5K and ranks in the 21st percentile nationally, indicating these ancillary therapies are present but not primary revenue drivers. This mix reinforces that the clinic’s core business is implant and cystoscopic procedures, with supportive stone and injection services.
Tenure and operational implication: The NPI was enumerated on 2010-03-22 (~16 years ago), indicating more than a decade of operation under this identifier. Given sustained high-volume billing on high-revenue implant and cystoscopy codes across Medicare and dominant in-state Medicaid cystoscopy billing, the center appears to be an established ambulatory surgical provider with entrenched procedural throughput in its specialty areas.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
28 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 80 | $13,790 | $1.1M |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 210 | $3,550 | $737.4K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 60 | $5,210 | $291.9K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 790 | $190 | $150.5K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 60 | $1,630 | $93K |
| 52204 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder and takes biopsies… | 140 | $580 | $79.9K |
| 55700 | Code deleted December 31, 2025. | 130 | $590 | $77.8K |
| 52332 | The provider performs cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 80 | $870 | $72K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 80 | $590 | $45.9K |
| 52351 | The provider performs a diagnostic cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the… | 40 | $1,050 | $37.8K |
Showing 1–10 of 28
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
28 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C9740 | 4 | 10 | 70 | $5,000 | $349.8K |
| 64590 | 2 | 20 | 30 | $6,100 | $201.4K |
| 64561 | 1 | 20 | 40 | $2,180 | $141.6K |
| J0585 | 22 | 30 | 5,890 | $1 | $46.9K |
| 52356 | 4 | 30 | 20 | $600 | $19.2K |
| 57288 | 1 | 10 | 10 | $1,450 | $18.8K |
| 52000 | 2 | 70 | 90 | $130 | $18.3K |
| 52281 | 5 | 20 | 30 | $320 | $17.1K |
| 52353 | 4 | 10 | 10 | $920 | $15.7K |
| 52601 | 17 | 20 | 20 | $740 | $15.6K |
Showing 1–10 of 28
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 790 | $90 | $67.7K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 450 | $0 | $0 |
| G8916 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time | 10 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 340 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Mississippi providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Mississippi median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1 | 10 | 70 | $90 | $16.4K |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 11 | 40 | 140 | $1 | $590 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 31 | 60 | 520 | $1 | $200 |
| G8916 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time | 4 | 10 | 70 | $0 | $0 |
Other providers in the same ZIP code as Oxford Urocare PLLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.